Follow The Filings

PAYX Paychex

Paychex earnings company data as of 4:48 AM ET 10/31

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 18 Dec EPS 1.30 — —
Rev — — —
FY2026 Q3 29 Sep EPS 1.33 — —
Rev $1.63B — —

Insider trades

Open-market buys and sales by PAYX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PAYX insider trades
  • $197K bought by 2 insiders
  • $4.6M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph M Velli Director
    Sale
    $844K 7,839 shares at $107.68 8.8% of stake
    Traded Oct 14 Filed Oct 16
  2. Robert L. Schrader CFO
    Sale
    $299K 2,600 shares at $115.09 12% of stake
    Traded Jul 20 Filed Jul 21
  3. Christopher C Simmons VP, Controller & Treasurer
    Sale
    $303K 2,615 shares at $115.92 43% of stake
    Traded Jul 17 Filed Jul 17
  4. Martin Mucci Chair
    Sale
    $2.7M 25,000 shares at $109.93 5.3% of stake
    Traded Jul 14 Filed Jul 15
  5. Joseph M Tucci Director
    Sale
    $384K 3,907 shares at $98.25 5.5% of stake
    Traded Jun 26 Filed Jun 30
  6. Elizabeth Roaldsen Sr. Vice President
    Sale
    $41K 459 shares at $90.00 4.7% of stake
    Traded May 13 Filed May 15
  7. Joseph Doody Director
    Buy
    $99K 1,000 shares at $98.76 New stake
    Traded Feb 4 Filed Feb 5
  8. Tom Bonadio Director
    Buy
    $98K 1,000 shares at $98.50 +4.9% to stake
    Traded Feb 4 Filed Feb 5

Also filed in the last 12 months, not counted as buying or selling: 25 share withholdings for taxes, 16 stock grants, 14 gifts, 3 other transactions, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
8-K 5.07
10-Q
8-K 2.02
DEF 14A
DEFA14A
8-K 5.02,9.01
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.